First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent (NOVA Trial)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 272 participants.

Also called NCT02578069

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 272 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02578069
Other papers using this trial's data
  • Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial JAMA neurology, 2022-02-01 DOI, PubMed 34982098, PMC8728659 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02578069. Randomized; single masking; primary purpose treatment. Start 2015-04-27 (actual); primary completion 2020-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent (NOVA Trial)
Acronym
NOVA
Intervention (Device)
NOVA Intracranial Sirolimus Eluting Stent System
Intervention (Device)
Apollo Intracranial Stent System
Lead sponsor
Sino Medical Sciences Technology Inc. (class: industry)
Collaborator
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct02578069
Content hash
1fd0b48d69284a85821d294715475154fc91d577130b11222212cbd735eae4ba